Oncotelic Therapeutics, Inc.
OTLC
Revenue
70.00k
▼-1.33M▼-95.00%
39 Months ChangeAssets
28.16M
▲1.48M▲5.53%
3 Months ChangeLiabilities
20.08M
▲792.75k▲4.11%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-29
Form 8-K
ID: 0001493152-26-004237
2026-01-26
Form 8-K
ID: 0001493152-26-003606
2026-01-07
Form 8-K
ID: 0001493152-26-000821
2026-01-06
Form 8-K
ID: 0001493152-26-000619
2026-01-06
Form 8-K
ID: 0001493152-26-000613
2025-12-30
Form 8-K
ID: 0001493152-25-029634
2025-12-23
Form 8-K
ID: 0001493152-25-028921
2025-12-09
Form 8-K
ID: 0001493152-25-026883
2025-11-17
Form 10-Q
ID: 0001493152-25-023834
2025-10-22
Form 8-K
ID: 0001493152-25-018877